Cashing in on a brand name | Indian Journal of Medical Ethics

A Journal of Healthcare Ethics & Humanities. Published since 1993 by Forum for Medical Ethics Society.
Peer-reviewed. Indexed in Medline, PubMed, The Philosopher’s Index, Scopus.

ISSN: 0975-5691 (Online); 0974-8466 (Print) RNI Reg No. MAHENG/2016/67188


Dublin Core		PKP Metadata Items	Metadata for this Document

1.	Title	Title of document	Cashing in on a brand name

2.	Creator	Author's name, affiliation, country	Vijay Thawani; Government Medical College, Nagpur 440003; IN

3.	Subject	Discipline(s)

3.	Subject	Keyword(s)

4.	Description	Abstract	Consumers in the Third World get third-rate treatment from the pharmaceutical industry, who sell them junk in the name of medicine. This includes formulations banned in the parent country of international giants. These companies have adopted a new technique: marketing new formulations under old brand names without informing consumers. These companies exploit people's faith in brand names and the resistance to generic prescriptions. They also hide behind antiquated laws which do not ban the launch of new formulations using old brand names.

5.	Publisher	Organizing agency, location	Forum for Medical Ethics Society

6.	Contributor	Sponsor(s)

7.	Date	(YYYY-MM-DD)	2016-11-30

8.	Type	Status & genre

8.	Type	Type

9.	Format	File format	HTML , PDF

10.	Identifier	Uniform Resource Identifier	https://ijme.in/articles/cashing-in-on-a-brand-name/

11.	Source	Title; vol., no. (year)	Indian Journal of Medical Ethics;: Drugs for AIDS: new ethical challenges

12.	Language	English=en	en

13.	Relation	Supp. Files

14.	Coverage	Geo-spatial location, chronological period, research sample (gender, age, etc.)

15.	Rights	Copyright and permissions	All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.